Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial

Table 4

Comparison of ET-1, NO, VEGF, and vWF before and after treatment.

	SMYZF group (n = 85), median (IQR)	Ginkgo group (n = 87), median (IQR)	value
ET-1 (pg/mL)
Before treatment	48.73 (24.86–96.48)	56.20 (31.22–146.48)	0.271
After treatment	22.04 (8.79–61.19)	30.85 (17.63–67.73)	0.043
NO (μmol/L)
Before treatment	16.06 (9.72–25.40)	15.14 (8.94–24.01)	0.614
After treatment	20.30 (11.26–36.82)	15.65 (9.04–26.86)	0.040
VEGF (pg/mL)
Before treatment	128.37 (76.14–216.21)	130.99 (56.13–189.34)	0.207
After treatment	301.47 (187.20–447.45)	308.16 (196.57–477.22)	0.491
vWF (ng/mL)
Before treatment	11643.45 (6466.81–15808.98)	9676.81 (6391.48–14450.25)	0.193
After treatment	9722.73 (6176.22–14078.82)	8913.02 (6278.56–13478.81)	0.385

Significant effect (<0.05).